David Piccioni - Concepedia

Author

David Piccioni

University of California San Diego ORCID

Also Known As

D Piccioni, D. E. Piccioni, D. Piccioni, D.E. Piccioni, DAVID E. PICCIONI, David E. Piccioni, David E Piccioni, David E. Piccioni, David Eric Piccioni, David Piccioni

258

Publications

6.9K

Citations

H-Index

104

Concepts

All Affiliations

University of California San Diego Andrews University University of Amsterdam Moores Cancer Center The Ohio State University

About

David Piccioni is an author at University of California San Diego specializing in medicine, oncology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.7K
2	Natural Sciences	12	12	749
3	Health Sciences	10	11	559
4	Engineering	8	8	1.1K
5	Public Health	1	1	47

David Piccioni

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Nature Medicine EngineeringTumor HeterogeneityPatient SelectionMedicinePersonalized Combination Therapy	2019	678
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Linda M. Liau, Keyoumars Ashkan, David D. Tran, Journal of Translational Medicine	2018	528
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Linda M. Liau, Keyoumars Ashkan, Steven Brem, JAMA Oncology	2022	356
Prevalence of<i>PDL1</i>Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors Aaron M. Goodman, David Piccioni, Shumei Kato, JAMA Oncology	2018	240
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner, Clinical Cancer Research	2020	230
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan, Science Translational Medicine Oncologic ImagingPathologyRecurrent High-grade GliomaHigh-grade GliomasGlioma	2016	196
Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases Natsuko Nomura, Sandra Pastorino, Pengfei Jiang, Cancer Cell International	2014	193
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC Timothy F. Cloughesy, Joseph Landolfi, Michael A. Vogelbaum, Neuro-Oncology	2018	174
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience Maria Schwaederlé, Barbara A. Parker, Richard B. Schwab, Molecular Cancer Therapeutics	2016	173
Measurement of the proton structure function F2 at very low Q2 at HERA J. Breitweg, S. Chekanov, M. Derrick, Physics Letters B Low Q2Nuclear PhysicsPhysicsNatural SciencesParticle Physics	2000	167

Page 1